Haw. Code R. § 17-1737-93 - Allogenic bone marrow transplant

(a) Indications for allogenic bone marrow transplant include:

(1) Severe aplastic anemia unresponsive to usual therapy;

(2) Acute myelogenous leukemia in first remission;

(3) Acute lymphocytic leukemia in second remission; and

(4) Chronic leukemia after first year.

(b) Conditions and limitations affecting allogenic bone marrow transplant include:

(1) Human leukocyte group A (HLA) histocompatible donor shall be available;

(2) Patient has no other major systemic disease which would result in poor potential for recovery (such as a heart condition, liver disease, kidney damage, brain lesions, cancer in other organs or lung disease);

(3) Patient shall have been properly evaluated by a qualified authority in Hawaii and bone marrow transplant is recommended as a possible curative procedure or if palliative, with reasonable likelihood for prolongation of life and return to an active life;

(4) No active infection at the time of the procedure;

(5) No general medical contraindication for the procedure and anesthesia;

(6) Informed consent shall be obtained from the patient or the patient's representative; and

(7) Age restricted to fifty or under except when identical twin is histocompatible and then age limit may be fifty-five.

Notes

Haw. Code R. § 17-1737-93

[Eff 08/01/94] (Auth: HRS § 346-14; 42 C.F.R. §431.10) (Imp: 42 C.F.R. §440.230; 42 U.S.C. §1396 b(i) )